Enalare Therapeutics Inc. is a clinical-stage biopharmaceutical company dedicated to developing and commercializing novel therapies for patients suffering from life-threatening acute respiratory and critical care conditions, including respiratory depression caused by drug overdose, post-surgery, and other conditions. The Company is planning to initiate pivotal studies for its lead compound ENA-001 in the near term.

Pharmaceutical

Enalare Therapeutics

Enalare Therapeutics' headquarters in Princeton, NJ, United States

Herm Cukier

Joseph Pergolizzi

Daniel Motto

Albert Dahan

David Battleman

Tj Gan

Gino Santini

Eugene Vortsman

Alexander Kraus

Joseph Petko

Bob Yedid

Mark Coleman

Description

People (1)

Daniel Motto

Jobs